GALLANT 22 Tesaglitazar vs. Placebo

PHASE3TerminatedINTERVENTIONAL
Enrollment

475

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

December 31, 2006

Conditions
Type 2 Diabetes
Interventions
DRUG

Tesaglitazar

BEHAVIORAL

Dietary and Lifestyle counseling

Trial Locations (101)

Unknown

Research Site, Adelaide

Research Site, Cairns

Research Site, Gosford

Research Site, Keswick

Research Site, Kippa-Ring

Research Site, Melbourne

Research Site, Miranda

Research Site, Nowra

Research Site, Wollongong

Research Site, Brno

Research Site, Hodonín

Research Site, Hradec Králové

Research Site, Pilsen

Research Site, Prague

Research Site, Příbram

Research Site, Semily

Research Site, Tábor

Research Site, Ústí nad Labem

Research Site, Paide

Research Site, Pärnu

Research Site, Tallinn

Research Site, Tartu

Research Site, Viljandi

Research Site, Angers

Research Site, Briollay

Research Site, Poitiers

Research Site, Saint-Benoît

Research Site, Saint-Ouen

Research Site, Toulouse

Research Site, Trélazé

Research Site, Athens

Research Site, Piraeus

Research Site, Balatonfüred

Research Site, Budapest

Research Site, Kaposvár

Research Site, Kecskemét

Research Site, Székesfehérvár

Research Site, Daugavpils

Research Site, Jēkabpils

Research Site, Madona

Research Site, Riga

Research Site, Sigulda

Research Site, Talsi

Research Site, Valmiera

Research Site, Kaunas

Research Site, Klaipėda

Research Site, Panevezys

Research Site, Vilnius

Research Site, Aursmoen

Research Site, Bergen

Research Site, Enebakk

Research Site, Fredrikstad

Research Site, Haugesund

Research Site, Hønefoss

Research Site, Inderøy

Research Site, Larvik

Research Site, Lierskogen

Research Site, Oslo

Research Site, Rolvsøy

Research Site, Cebu City

Research Site, Pasig

Research Site, Quezon City

Research Site, Katowice

Research Site, Bialystok

Research Site, Bydgoszcz

Research Site, Gdansk

Research Site, Krakow

Research Site, Lodz

Research Site, Lublin

Research Site, Olsztyn

Research Site, Poznan

Research Site, Radom

Research Site, Rzeszów

Research Site, Sopot

Research Site, Szczecin

Research Site, Toruñ

Research Site, Tychy

Research Site, Warsaw

Research Site, Wroclaw

Research Site, Zabrze

Research Site, Zielona Góra

Research Site, Belgrade

Research Site, Dolný Kubín

Research Site, Levice

Research Site, Lučenec

Research Site, Ľubochňa

Research Site, Nové Zámky

Research Site, Považská Bystrica

Research Site, Šahy

Research Site, Trenčín

Research Site, Veľký Meder

Research Site, Žilina

Research Site, Åmål

Research Site, Borås

Research Site, Gothenburg

Research Site, Mölndal

Research Site, Partille

Research Site, Skene

Research Site, Stenungsund

Research Site, Uddevalla

Research Site, Vänersborg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY